Disease-specific quality of life in patients with lupus nephritis

Jolly M., Toloza S., Goker B., Clarke A. E., Navarra S. V., Wallace D., ...Daha Fazla

LUPUS, cilt.27, sa.2, ss.257-264, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 27 Sayı: 2
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1177/0961203317717082
  • Dergi Adı: LUPUS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.257-264
  • Anahtar Kelimeler: Systemic lupus erythematosus, lupus nephritis, quality of life, LupusPRO, ERYTHEMATOSUS, SLE, CYCLOPHOSPHAMIDE, MORTALITY, MOFETIL, THERAPY, TRIAL
  • Gazi Üniversitesi Adresli: Evet

Özet

Background Patient-reported outcomes in lupus nephritis (LN) are not well studied. Studies with disease-targeted PRO tool in LN do not exist. Herein, we describe quality of life (QOL: HRQOL & non-HRQOL) among LN patients using LupusPRO.